
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
AlloStem Therapeutics is working toward the discovery and development of targeted cancer therapies specifically MEK kinase (RAS pathway) as a target.
Headlines from Mass High Tech about ALLOSTEM THERAPEUTICS LLC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2010 |
| Ownership Type | Private/Minority owned |
| Venture Funding | Subscriber access only |
| No. of Employees at this location | Subscriber access only |
| Anticipated Workforce Changes | Subscriber access only |
| Foreign Distribution | Subscriber access only |
| Uday Khire | CEO |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Farmington, CT |
| Size | Subscriber access only |
| Website | http://www.allostem.com |
| Revenue | Subscriber access only |
| Address | 400 Farmington Ave Farmington, CT, 06032 |
| Phone | 860-679-6893 |
| Subscriber access only | |
| Website | www.allostem.com |